 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/04/2026 |
$65.79 |
$66.64 |
$65.52 |
$66.53 |
2.30M | | 09/08/2026 |
$65.24 |
$66.26 |
$64.01 |
$64.63 |
1.46M | | 09/09/2026 |
$63.83 |
$65.33 |
$63.64 |
$64.41 |
1.95M | | 09/10/2026 |
$64.41 |
$65.59 |
$63.57 |
$65.51 |
2.20M | | 09/11/2026 |
$65.96 |
$66.05 |
$65.29 |
$65.68 |
1.60M |
 |
| BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. | |
 |

BioMarin Pharmaceutical (BMRN) has the following price history information. Looking back at BMRN historical stock prices for the last five trading days, on September 04, 2026, BMRN opened at $65.79, traded as high as $66.64 and as low as $65.52, and closed at $66.53. Trading volume was a total of 2.30M shares. On September 08, 2026, BMRN opened at $65.24, traded as high as $66.26 and as low as $64.01, and closed at $64.63. Trading volume was a total of 1.46M shares. On September 09, 2026, BMRN opened at $63.83, traded as high as $65.33 and as low as $63.64, and closed at $64.41. Trading volume was a total of 1.95M shares. On September 10, 2026, BMRN opened at $64.41, traded as high as $65.59 and as low as $63.57, and closed at $65.51. Trading volume was a total of 2.20M shares. On September 11, 2026, BMRN opened at $65.96, traded as high as $66.05 and as low as $65.29, and closed at $65.68. Trading volume was a total of 1.60M shares.
BMRN Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into BioMarin Pharmaceutical shares, starting with a $10,000 purchase of BMRN, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/14/2016 |
|
| End date: |
09/11/2026 |
|
| Start price/share: |
$95.30 |
|
| End price/share: |
$65.68 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-31.08% |
|
| Average Annual Total Return: |
-3.65% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$6,895.43 |
|
| Years: |
10.00 |
|
|
 |
| Date |
Close |
| 09/04/2026 | $66.53 | | 09/08/2026 | $64.63 | | 09/09/2026 | $64.41 | | 09/10/2026 | $65.51 | | 09/11/2026 | $65.68 |
|
 |